Wu, Yifang 吳以芳
Pay records
Click on "Organisation" or "Year-end" to sort by firm or year. Click on the date to see all the pay of the organisation for that year.
Some data are hidden to fit your display. Rotate?
| Organisation | Last position |
Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total |
|---|---|---|---|---|---|---|---|---|
2024 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Ch | 2024-12-31 | 3,106 | 1,620 | 71 | 4,797 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2024-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2024-12-31 | ||||||
| Total | 0 | 3,106 | 1,620 | 71 | 0 | 4,797 | ||
2023 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Ch | 2023-12-31 | 3,541 | 10,093 | 71 | 13,705 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2023-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2023-12-31 | ||||||
| Total | 0 | 3,541 | 10,093 | 71 | 0 | 13,705 | ||
2022 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Ch | 2022-12-31 | 3,417 | 10,696 | 62 | 14,174 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2022-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2022-12-31 | ||||||
| Total | 0 | 3,417 | 10,696 | 62 | 0 | 14,174 | ||
2021 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Ch, CEO | 2021-12-31 | 3,606 | 9,835 | 49 | 13,490 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2021-12-31 | ||||||
| SINOPHARM GROUP CO. LTD. | Ind Sup, Ch | 2021-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2021-12-31 | ||||||
| Total | 0 | 3,606 | 9,835 | 49 | 0 | 13,490 | ||
2020 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Ch, CEO | 2020-12-31 | 3,158 | 7,784 | 4 | 10,945 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2020-12-31 | ||||||
| SINOPHARM GROUP CO. LTD. | Ind Sup, Ch | 2020-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2020-12-31 | ||||||
| Total | 0 | 3,158 | 7,784 | 4 | 0 | 10,945 | ||
2019 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Pres, CEO | 2019-12-31 | 2,800 | 4,494 | 55 | 7,349 | ||
| Shanghai Henlius Biotech, Inc. | NED | 2019-12-31 | ||||||
| SISRAM MEDICAL LTD | NED | 2019-12-31 | ||||||
| Total | 0 | 2,800 | 4,494 | 55 | 0 | 7,349 | ||
2018 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Pres, CEO | 2018-12-31 | 8,117 | 1,093 | 57 | 222 | 9,489 | |
| SISRAM MEDICAL LTD | NED | 2018-12-31 | ||||||
| Total | 0 | 8,117 | 1,093 | 57 | 222 | 9,489 | ||
2017 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Pres, CEO | 2017-12-31 | 3,944 | 3,312 | 55 | 649 | 7,961 | |
| SISRAM MEDICAL LTD | NED | 2017-12-31 | ||||||
| Total | 0 | 3,944 | 3,312 | 55 | 649 | 7,961 | ||
2016 HKD'000 |
||||||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Pres, CEO | 2016-12-31 | 1,788 | 2,857 | 47 | 1,437 | 6,129 | |
| Total | 0 | 1,788 | 2,857 | 47 | 1,437 | 6,129 | ||
Notes
- These data are incomplete. They are entered and checked by volunteers, so if you want to expand them then volunteer to be a Webb-site editor and add pay records from annual reports! Please report any errors.
- If a director sits on the boards of both a listed company and its listed subsidiary, then the parent company records will normally include the pay at the subsidiary, so you should subtract that when looking at annual totals.
Copyright & disclaimer, Privacy policy